TNFRSF17 and rheumatoid arthritis: Finally, the synovial expression of B-cell maturation antigen (BCMA/TNFRSF17), a critical survival receptor for plasma cells was also increased in early RA compared to normal controls and inhibited after treatment with tDMARD (Fig 4C).